Search

Author/Creator Met, Ö

1. 1132PDClinical efficacy of T-cell therapy after short-term BRAF-inhibitor induction in checkpoint inhibitor resistant metastatic melanoma patients. (23rd October 2018)

Authors:
Borch, T H; Andersen, R; Rana, M A H; Kongsted, P; Pedersen, M; Nielsen, M; Kjeldsen, J W; Kverneland, A; Lorentzen, C L; Met, Ö; Donia, M; Svane, I M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression. (24th April 2018)

Authors:
Andersen, R; Borch, T H; Draghi, A; Gokuldass, A; Rana, M A H; Pedersen, M; Nielsen, M; Kongsted, P; Kjeldsen, J W; Westergaard, M C W; Radic, H D; Chamberlain, C A; Hölmich, L R; Hendel, H W; Larsen, M S; Met, Ö; Svane, I M; Donia, M
Journal:
Annals of oncology
Issue:
Volume 29:Number 7(2018)
Page Start:
1575
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗